HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Abstract
Glial cells play an important role in sequestering neuronally released glutamate via Na+-dependent transporters. Surprisingly, these transporters are not operational in glial-derived tumors (gliomas). Instead, gliomas release glutamate, causing excitotoxic death of neurons in the vicinity of the tumor. We now show that glutamate release from glioma cells is an obligatory by-product of cellular cystine uptake via system xc-, an electroneutral cystine-glutamate exchanger. Cystine is an essential precursor for the biosynthesis of glutathione, a major redox regulatory molecule that protects cells from endogenously produced reactive oxygen species (ROS). Glioma cells, but not neurons or astrocytes, rely primarily on cystine uptake via system xc- for their glutathione synthesis. Inhibition of system xc- causes a rapid depletion of glutathione, and the resulting loss of ROS defense causes caspase-mediated apoptosis. Glioma cells can be rescued if glutathione status is experimentally restored or if glutathione is substituted by alternate cellular antioxidants, confirming that ROS are indeed mediators of cell death. We describe two potent drugs that permit pharmacological inhibition of system xc-. One of these drugs, sulfasalazine, is clinically used to treat inflammatory bowel disease and rheumatoid arthritis. Sulfasalazine was able to reduce glutathione levels in tumor tissue and slow tumor growth in vivo in a commonly used intracranial xenograft animal model for human gliomas when administered by intraperitoneal injection. These data suggest that inhibition of cystine uptake into glioma cells through the pharmacological inhibition of system xc- may be a viable therapeutic strategy with a Food and Drug Administration-approved drug already in hand.
AuthorsWook Joon Chung, Susan A Lyons, Gina M Nelson, Hashir Hamza, Candece L Gladson, G Yancey Gillespie, Harald Sontheimer
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 25 Issue 31 Pg. 7101-10 (Aug 03 2005) ISSN: 1529-2401 [Electronic] United States
PMID16079392 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amino Acid Transport Systems
  • Benzoates
  • DNA, Neoplasm
  • Sulfasalazine
  • Cystine
  • 4-carboxyphenylglycine
  • Caspases
  • Glutathione
  • Glycine
Topics
  • Amino Acid Transport Systems (antagonists & inhibitors, metabolism)
  • Animals
  • Apoptosis
  • Benzoates (pharmacology)
  • Brain Neoplasms (metabolism, pathology, physiopathology)
  • Caspases (metabolism)
  • Cell Division (drug effects)
  • Cystine (antagonists & inhibitors)
  • DNA, Neoplasm (antagonists & inhibitors)
  • Glutathione (antagonists & inhibitors)
  • Glycine (analogs & derivatives, pharmacology)
  • Humans
  • Rats
  • Rats, Sprague-Dawley
  • Sulfasalazine (pharmacology)
  • Time Factors
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: